Bone tumour (giant cell)
Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone
Who can joinAdults
Age18+ years
Kind of studyPhase 3: compared with usual treatment
What it testsA medicine
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Where to go
1 hospital in India taking patients for this trial.
All India Institute of Medical ScienceNew DelhiDirections ↗
Registry summary (technical)
The purpose of the clinical study is to investigate whether the local delivery of bisphosphonate as a surgical adjuvant can decrease the chance of a giant cell tumor of bone coming back to the same location. The hypothesis is that the local administration of bisphosphonate will decrease the rate of the tumor returning compared to traditional aggressive surgical removal of the tumor.
Sponsor: St. Louis University
NCT03295981 on ClinicalTrials.gov
Last updated on the registry 22 Apr 2026 · read by us 20 Oct 2026